Suchergebnisse - "Downey, Louise"

PubPharm (5)

1

The changing landscape for the management of patients with neovascular AMD : brolucizumab in clinical practice

enthalten in: Eye (London, England) | 2022

von Pearce, I. | Amoaku, W. | Bailey, C. | +9

2

Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment : 18-Month, Multicenter, Phase IIIB RELIGHT Study

enthalten in: Ophthalmology | 2015

von Pearce, I. | Banerjee, S. | Burton, B. | +11

3

UK AMD EMR USERS GROUP REPORT V : benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12

enthalten in: The British journal of ophthalmology | 2015

von Lee, A. | Lee, C. | Butt, T. | +34

4

The neovascular age-related macular degeneration database : report 2: incidence, management, and visual outcomes of second treated eyes

enthalten in: Ophthalmology | 2014

von Zarranz-Ventura, J. | Liew, G. | Johnston, R. | +55

5

The neovascular age-related macular degeneration database : multicenter study of 92 976 ranibizumab injections: report 1: visual acuity

enthalten in: Ophthalmology | 2014

von Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group | Tufail, A. | Xing, W. | +15

CommentIn: Eye (Lond). 2023 Dec;37(17):3521-3522. - PMID 37142778

1
[1]